Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

An analysis of pancreatic cancer data in younger adults found that while there is an increasing incidence of pancreatic cancer in young adults, the mortality rate remains stable.

Pancreatic cancer develops quietly, with symptoms that may seem insignificant at first glance. This cancer affects the ...

Pancreatic cancer is one of the deadliest cancers, with a five-year survival rate of only seven percent - and with symptoms ...

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.

CD40 agonists have had mixed results in cancer to date, with Roche discontinuing its selicrelumab candidate after ...

Most cases of pancreatic cancer don’t cause any symptoms until the disease is locally advanced or metastatic, meaning the cancer has spread to another part of the body, Marcovalerio Melis ...

Radiation therapy: Radiation therapy is primarily used in advanced cases to reduce pain and provide palliative care, ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on RenovoRx (RNXT – Research Report). The associated price target ...

For patients facing a pancreatic cancer diagnosis, a compassionate approach to care can be transformative. Yet, a new study ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...